Related Experiment Videos
Vitamin a deficiency in patients with common variable immunodeficiency
Sara Sebnem Kilic1, Esra Yapici Kezer, Yesim Ozarda Ilcol
1Department of Pediatric Immunology, Uludag University School of Medicine, Bursa, Turkey. sebnemkl@uludag.edu.tr
Journal of Clinical Immunology
|June 28, 2005
Summary
Common variable immunodeficiency (CVID) patients exhibit low Vitamin A and high neopterin levels. Vitamin A supplementation may help reduce inflammation in CVID patients, influencing cytokine production.
Area of Science:
- Immunology
- Nutrition Science
- Biochemistry
Background:
- Vitamin A is an antioxidant micronutrient with immunomodulating effects.
- Vitamin A deficiency is linked to altered cytokine profiles, shifting towards type 1 cytokines.
- Immunodeficiency disorders like CVID involve dysregulated immune responses.
Purpose of the Study:
- To assess Vitamin A status in patients with Common Variable Immunodeficiency (CVID).
- To investigate the relationship between Vitamin A levels and cytokine production in CVID patients.
- To explore the in vitro effects of a Vitamin A derivative on cytokine production.
Main Methods:
- Serum levels of Vitamin A, neopterin, TNF-alpha, IL-2, IL-4, and IL-10 were measured in 19 CVID patients and 15 healthy children.
- Lymphocyte cultures from CVID patients and healthy controls were treated with 9-cis retinal, a Vitamin A derivative.
- Cytokine production (TNF-alpha, IL-2, IL-4, IL-10) was analyzed in vitro.
Main Results:
- CVID patients had significantly lower serum Vitamin A (21.1 μg/dL) compared to healthy children (35.7 μg/dL).
- Serum neopterin levels were significantly higher in CVID patients (9.8 nmol/L) than in controls (3.9 nmol/L).
- CVID patients showed significantly lower serum IL-4 levels, while TNF-alpha, IL-2, and IL-10 levels were similar between groups.
Conclusions:
- CVID patients present with suboptimal Vitamin A status and elevated neopterin levels.
- In vitro, a Vitamin A derivative (9-cis retinal) enhanced the production of TNF-alpha, IL-4, and IL-2 in mononuclear cells.
- Vitamin A supplementation could potentially modulate inflammatory responses in CVID patients.